News Digest / Ticker: DRMA

Ticker: DRMA

10:03am, Wednesday, May 14, 2025

Dermata Therapeutics Reports Mixed Q1 Results: Cost Reductions Amid Ongoing Financial Challenges

Dermata Therapeutics, Inc. (NASDAQ: DRMA) has disclosed its financial results for the first quarter ending March 31, 2025, highlighting both positive developments and challenges. Key Financial Highlights: Operating Expenses: Total operating expenses decreased from $3.2 million (Q1 2024) to $2.3 ...